focus -WSS

focus

author：explore 2025-09-14 10:10:18 - browse：23

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Think you might have Covid

entertainment

WSS

Alabama IVF ruling threatens families facing fatal genetic disease

The Harvard botanist who searched for psychedelics in the Amazon

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Eli Lilly, Pfizer, and others want in on the online prescription market

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Independent physicians launch a new lobbying group

hotspot

focus

leisure time

In Memoriam: Notable people who died in 2023

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

In Memoriam: Notable people who died in 2023

Prior authorization will have to move faster under new Biden rule

United colonoscopy coverage change 'may cost lives,' doctors say

Prior authorization will have to move faster under new Biden rule

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Test for long Covid? Researchers find new clue in blood samples

What does generative AI mean for health care? We asked experts

Ed Silverman on new gene therapies, biosimilars, coffee, and more

knowledge

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Eli Lilly, Pfizer, and others want in on the online prescription market

Alabama hospital puts IVF treatments on hold

Copay coupons to count toward deductibles, after Biden court move

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Parkinson’s finding may lead to tests and, someday, treatments

explore

entertainment

focus

Wikipedia